How much funding has Bicycle Therapeutics raised?

Bicycle Therapeutics has raised $555.0M in total funding, most recently a Private Equity round.

Who are Bicycle Therapeutics's investors?

Bicycle Therapeutics's investors include Deep Track Capital, Atlas Venture, EcoR1 Capital, Fairmount, Forbion Capital Partners, Novartis Venture Fund.

When was Bicycle Therapeutics founded?

Bicycle Therapeutics was founded in 2009.

Where is Bicycle Therapeutics headquartered?

Bicycle Therapeutics is headquartered in Cambridge, Massachusetts, United States.

What industry is Bicycle Therapeutics in?

Bicycle Therapeutics operates in Biotech, Oncology, pharmaceuticals.

How many employees does Bicycle Therapeutics have?

Bicycle Therapeutics has 201-500 employees.

Bicycle Therapeutics

IPO

Cambridge, United States · Founded 2009 · $555.0M raised

Biotech

Oncology

pharmaceuticals

Headquarters: Cambridge, Massachusetts
Employees: 201–500
Founded: 2009
Business Model: B2B

Total Funding: $555.0M
Last Round: $555.0M Private EquityJan 2024
Rounds: 2

About

Bicycle Therapeutics is a clinical-stage biopharmaceutical company pioneering bicyclic peptide (Bicycle) therapeutics, a novel class of precision-guided medicines combining biologic pharmacology with small-molecule manufacturing advantages. Founded in 2009 based on Nobel Prize-winning phage display research by Sir Greg Winter, the company focuses on oncology and is headquartered in Cambridge, UK with a growing presence in Boston, Massachusetts.

Summary

Bicycle Therapeutics is a Biotech company based in Cambridge, United States, founded in 2009. It has raised $555.0M in total across 2 rounds, most recently a $555.0M Private Equity round in Jan 2024. Investors include Deep Track Capital, Atlas Venture and EcoR1 Capital.